Robotic Assisted Early Mobilization in Ventilated ICU Patients
Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Jun 6, 2020
Trial Information
Current as of July 22, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years
- • Invasive mechanically ventilated and expected to be ventilated for another 24 hours
- • Cardiovascular stability, allowing mobilization
- • Respiratory stability, allowing mobilization
- Exclusion Criteria:
- • Bed-bound before ICU admission
- • Bed-rest order or contraindication of weight load of the lower extremity or spine
- • Severe skin lesions or fasciitis in the area of contact with the device or rhabdomyolysis
- • Fresh SAB, ICB or elevated ICP
- • Status epilepticus
- • Acute intoxication
- • Shock with catecholamine doses \>0.3µg/kg/min or acute bleeding including organ ruptures
- • Multiorgan failure with lactate \> 4 mmol/l
- • Body height outside the range 150-195 cm
- • Body weight outside the range 45-135 kg
- • pAVK IV°
- • Pacemakers or other electrical stimulators
- • Implanted medical pumps
- • Pregnancy
- • Life expectancy below 7 days or acute palliative care situation
- • Death inevitable or maximum therapy is not carried out by the treating physicians or due to patient's request
- • Unable to understand the official language
- • ICU stay \> 72h at the time of enrolment
- • Translated with www.DeepL.com/Translator (free version)
About Charite University, Berlin, Germany
Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berlin Mitte, Berlin, Germany
Patients applied
Trial Officials
Stefan J Schaller, MD
Principal Investigator
Charite University, Berlin, Germany
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials